FrontPage is India's Stock Market Social Network

Join 50,000+ Traders and Investors

VENUSREM Share Price Discussion

Venus Remedies Ltd.
Sector: Pharmaceuticals and health care

VENUSREM Share Price *

25.95 +0 (0%)

* (quote may be delayed)

Find answers to all your questions on live VENUSREM message board: Is VENUSREM buy or sell? Should I buy VENUSREM shares? Why are VENUSREM shares falling? Should I invest in VENUSREM stock?

VENUSREM Discussion Forum

NewsBot @newsbot

VENUSREM

•

Oct 17 2:03 AM

FAL Corp sells entire stake in ICICI Lombard; Axis Trustee offloads 12.93 lakh shares of Rel Cap
SK Growth Fund acquired 2,45,459 shares of newly listed Vishwaraj Sugar Industries at Rs 60.35 per share.

Moneycontrol

https://www.moneycontrol.com/news/business/markets/fal-co...

NewsBot @newsbot

VENUSREM

•

Feb 18 4:57 PM

Venus Remedies Standalone December 2018 Net Sales at Rs 69.06 crore, down 25.84% Y-o-Y
https://www.moneycontrol.com/news/business/earnings/venus-remedies-standalone-december-2018-net-sales-at-rs-69-06-crore-down-25-84-y-o-y-3550301.html

NewsBot @newsbot

VENUSREM

•

Nov 16 4:17 PM

Venus Remedies soars after positive clinical trial results for flagship product
https://www.moneycontrol.com/news/business/markets/venus-remedies-soars-after-positive-clinical-trial-results-for-flagship-product-3185931.html

NewsBot @newsbot

VENUSREM

•

Nov 15 5:52 PM

Venus Remedies Standalone September 2018 Net Sales at Rs 80.89 crore, down 10.63% Y-o-Y
https://www.moneycontrol.com/news/business/earnings/venus-remedies-standalone-september-2018-net-sales-at-rs-80-89-crore-down-10-63-y-o-y-3178131.html

VENUSREM - Share Price - Fundamentals
Market Capitalization 40.91
Enterprise Value 379.37
Price to Earnings 25.4
Price to Book Value 0.12
Return on Capital Employed 0.02
Return on Equity -0.07
Face Value 10
Dividend Yield NA
VENUSREM Share Price - Technicals
VENUSREM - 52 Week High ₹68
VENUSREM - 52 Week Low ₹18.8
VENUSREM Share Price - Historical (₹)
Date Open High Low Close
Oct 24 26.6 29.1 25.15 25.95
Oct 23 29.85 29.85 27.85 27.85
Oct 22 33.7 33.7 30.9 30.9
Oct 18 33.85 35.3 30.95 34.3
Oct 17 27.8 31.2 27.4 29.5
VENUSREM Share Price - Daily Moving Averages (DMA)
20 Day Moving Average ₹24.06
30 Day Moving Average ₹23.87
50 Day Moving Average ₹23.61
100 Day Moving Average ₹24.36
200 Day Moving Average ₹29.74
VENUSREM - Profit And Loss
CONSOLIDATED Mar-18 Mar-17 % Change
Revenue 355 375.45 -0.05
Operating Profit 43 75.04 -0.43
Profit Before Tax -23 1.05 -22.9
Net Income -27 4.75 -6.68
VENUSREM - Balance Sheet
CONSOLIDATED Mar-19 Mar-18 % Change
Shareholder's Funds 341 368 -0.07
Total Liabilities 391 380 0.03
Total Assets 732 749 -0.02
VENUSREM - Cash Flow
CONSOLIDATED Mar-18 Mar-17 % Change
Cash from Operating Activity 52 102.56 -0.49
Cash from Investing Activity -11 -45.87 -0.76
Cash from Financing Activity -40 -56.58 -0.29
Net Cash Flow NA 0.11 -1
VENUSREM - Ratios
CONSOLIDATED Mar-18 Mar-17
Return on Assets -0.04 0.01
Return on Equity -0.07 0.01
Return on Capital Employed 0.02 0.05
VENUSREM - 3 year Growth
3 Year CAGR Growth in Revenue -0.21
3 Year CAGR Growth in Operating Profit -0.51
3 Year CAGR Growth in EBIDTA -0.5
3 Year CAGR Growth in Net Income -6.93
3 Yr CAGR Growth - Diluted EPS -6.48
VENUSREM - 5 year Growth
5 Year CAGR Growth in Revenue -0.23
5 Year CAGR Growth in Operating Profit -0.64
5 Year CAGR Growth in EBIDTA -0.63
5 Year CAGR Growth in Net Income -1.47
3 Yr CAGR Growth - Diluted EPS -1.4
VENUSREM - Recent News
NewsBot
Oct 17 2:03 AM
FAL Corp sells entire stake in ICICI Lombard; Axis Trustee offloads 12.93 lakh shares of Rel Cap
Moneycontrol
NewsBot
Feb 18 4:57 PM
Venus Remedies Standalone December 2018 Net Sales at Rs 69.06 crore, down 25.84% Y-o-Y
https://www.moneycontrol.com/news/business/earnings/venus-remedies-standalone-december-2018-net-sales-at-rs-69-06-crore-down-25-84-y-o-y-3550301.html
NewsBot
Nov 16 4:17 PM
Venus Remedies soars after positive clinical trial results for flagship product
https://www.moneycontrol.com/news/business/markets/venus-remedies-soars-after-positive-clinical-trial-results-for-flagship-product-3185931.html
NewsBot
Nov 15 5:52 PM
Venus Remedies Standalone September 2018 Net Sales at Rs 80.89 crore, down 10.63% Y-o-Y
https://www.moneycontrol.com/news/business/earnings/venus-remedies-standalone-september-2018-net-sales-at-rs-80-89-crore-down-10-63-y-o-y-3178131.html
VENUSREM - Related Communities
WANBURY
Wanbury Ltd. Sector: Pharmaceuticals ...
PIRPHYTO
Piramal Phytocare Ltd. Sector: Pharma...
PARABDRUGS
Parabolic Drugs Ltd. Sector: Pharmace...
ORCHIDPHAR
Orchid Pharma Ltd. Sector: Pharmaceut...
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Lt...
WOCKPHARMA
Wockhardt Ltd. Sector: Pharmaceutical...
VIVIMEDLAB
Vivimed Labs Ltd. Sector: Pharmaceuti...
VENUSREM
Venus Remedies Ltd. Sector: Pharmaceu...
UNICHEMLAB
Unichem Laboratories Ltd. Sector: Pha...
TTKHLTCARE
TTK Healthcare Ltd. Sector: Pharmaceu...

Market Capitalization	40.91
Enterprise Value	379.37
Price to Earnings	25.4
Price to Book Value	0.12
Return on Capital Employed	0.02
Return on Equity	-0.07
Face Value	10
Dividend Yield	NA

VENUSREM - 52 Week High	₹68
VENUSREM - 52 Week Low	₹18.8

Date	Open	High	Low	Close
Oct 24	26.6	29.1	25.15	25.95
Oct 23	29.85	29.85	27.85	27.85
Oct 22	33.7	33.7	30.9	30.9
Oct 18	33.85	35.3	30.95	34.3
Oct 17	27.8	31.2	27.4	29.5

20 Day Moving Average	₹24.06
30 Day Moving Average	₹23.87
50 Day Moving Average	₹23.61
100 Day Moving Average	₹24.36
200 Day Moving Average	₹29.74

CONSOLIDATED	Mar-18	Mar-17	% Change
Revenue	355	375.45	-0.05
Operating Profit	43	75.04	-0.43
Profit Before Tax	-23	1.05	-22.9
Net Income	-27	4.75	-6.68

CONSOLIDATED	Mar-19	Mar-18	% Change
Shareholder's Funds	341	368	-0.07
Total Liabilities	391	380	0.03
Total Assets	732	749	-0.02

CONSOLIDATED	Mar-18	Mar-17	% Change
Cash from Operating Activity	52	102.56	-0.49
Cash from Investing Activity	-11	-45.87	-0.76
Cash from Financing Activity	-40	-56.58	-0.29
Net Cash Flow	NA	0.11	-1

CONSOLIDATED	Mar-18	Mar-17
Return on Assets	-0.04	0.01
Return on Equity	-0.07	0.01
Return on Capital Employed	0.02	0.05

3 Year CAGR Growth in Revenue	-0.21
3 Year CAGR Growth in Operating Profit	-0.51
3 Year CAGR Growth in EBIDTA	-0.5
3 Year CAGR Growth in Net Income	-6.93
3 Yr CAGR Growth - Diluted EPS	-6.48

5 Year CAGR Growth in Revenue	-0.23
5 Year CAGR Growth in Operating Profit	-0.64
5 Year CAGR Growth in EBIDTA	-0.63
5 Year CAGR Growth in Net Income	-1.47
3 Yr CAGR Growth - Diluted EPS	-1.4

SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

FrontPage Apps

Help About Privacy Terms Disclaimers Refunds

VENUSREM Share Price Discussion

VENUSREM Discussion Forum

VENUSREM - Share Price - Fundamentals

VENUSREM Share Price - Technicals

VENUSREM Share Price - Historical (₹)

VENUSREM Share Price - Daily Moving Averages (DMA)

VENUSREM - Profit And Loss

VENUSREM - Balance Sheet

VENUSREM - Cash Flow

VENUSREM - Ratios

VENUSREM - 3 year Growth

VENUSREM - 5 year Growth

VENUSREM - Recent News

VENUSREM - Related Communities